Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
US Army
Deloitte
Mallinckrodt
Accenture
Citi
Express Scripts
McKesson
Federal Trade Commission

Generated: April 26, 2018

DrugPatentWatch Database Preview

SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE Drug Profile

« Back to Dashboard

Which patents cover Spironolactone And Hydrochlorothiazide, and what generic alternatives are available?

Spironolactone And Hydrochlorothiazide is a drug marketed by Ascot, Mutual Pharm, Mylan, Purepac Pharm, Sun Pharm Industries, Superpharm, Watson Labs, and Yaopharma Co Ltd. and is included in eight NDAs.

The generic ingredient in SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE is hydrochlorothiazide; spironolactone. There are thirty-two drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; spironolactone profile page.
Drug patent expirations by year for SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE
Pharmacology for SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE
Ingredient-typeThiazides
Drug ClassAldosterone Antagonist
Thiazide Diuretic
Mechanism of ActionAldosterone Antagonists
Physiological EffectIncreased Diuresis
Synonyms for SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE
C24H32O4S.C7H8ClN3O4S2
Hydrochlorothiazide / Spironolactone
HYDROCHLOROTHIAZIDE; SPIRONOLACTONE
LS-178649
MP 40 [Pill Imprint]
SCHEMBL930086
Spiridazide
SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE
Spironolactone-hydrochlorothiazide
Spironothiazid
Uractazide

US Patents and Regulatory Information for SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ascot SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; spironolactone TABLET;ORAL 088025-001 Nov 23, 1984 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; spironolactone TABLET;ORAL 087398-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Purepac Pharm SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; spironolactone TABLET;ORAL 087999-001 Nov 6, 1985 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Yaopharma Co Ltd SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; spironolactone TABLET;ORAL 086881-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Harvard Business School
Express Scripts
Fuji
Covington
US Department of Justice
Daiichi Sankyo
QuintilesIMS
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.